NASD · Healthcare · Diagnostics & Research · Belgium
MDxHealth SA is a micro cap company (market value under $300 million) in the Diagnostics & Research industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the MDxHealth SA stock.
No reliable verdict: intrinsic value $3.35 per share, market price $0.15 (as of 2026-11-17).
A revenue multiple, discounted for its losses, would put the shares at $3.35: 22 times the price of $0.15. A multiple has nothing to stand on when a company earns almost nothing on its sales and has no filings in our archive, so we do not publish a verdict on this one.
All 44 Diagnostics & Research stocks
We do not publish a verdict on MDXH. A revenue multiple, discounted for its losses, would put the shares at $3.35: 22 times the price of $0.15. A multiple has nothing to stand on when a company earns almost nothing on its sales and has no filings in our archive, so we do not publish a verdict on this one.
We do not publish one (as of the 2026-11-17 close). A revenue multiple, discounted for its losses, would put the shares at $3.35: 22 times the price of $0.15. A multiple has nothing to stand on when a company earns almost nothing on its sales and has no filings in our archive, so we do not publish a verdict on this one.